Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial

NCT01417104 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT01417104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial
Lead sponsor
Ohio State University
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2009
Completion date
January 31, 2012
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis